A new study from Princeton has revealed how a synthetic protein revives E. coli cells that lack a life-sustaining gene, offering insight into how life can adapt to survive and potentially be reinvented.
Researchers in the Hecht lab discovered the unexpected way in which a synthetic protein called SynSerB promotes the growth of cells that lack the natural SerB gene, which encodes an enzyme responsible for the last step in the production of the essential amino acid serine. The findings were published in the Proceedings of the National Academy of Sciences.
The Hecht group first discovered SynSerB’s ability to rescue serine-depleted E. coli cells in 2011. At that time, they also discovered several other de novo proteins capable of rescuing the deletions of three other essential proteins in E. coli. “These are novel proteins that have never existed on Earth, and aren’t related to anything on Earth yet they enable life to grow where it otherwise would not,” said Michael Hecht, professor of chemistry at Princeton and corresponding author on the article.
Natural proteins are complex molecular machines constructed from a pool of twenty different amino acids. Typically they range from several dozen to several hundred amino acids in length. In principle, there are more possible protein sequences than atoms in the universe, but through evolution Nature has selected just a small fraction to carry out the cellular functions that make life possible.
“Those proteins must be really special,” Hecht said. “The driving question was, ‘Can we do that in the laboratory? Can we come up with non-natural sequences that are that special, from an enormous number of possibilities?”
To address this question, the Hecht lab developed a library of non-natural proteins guided by a concept called binary design. The idea was to narrow down the number of possible sequences by choosing from eleven select amino acids that were divided into two groups: polar and non-polar. By using only the polar or non-polar characteristics of those amino acids, the researchers could design a plethora of novel proteins to fold into a particular shape based on their affinity to and repulsion from water. Then, by allowing the specific positions to have different amino acids, the researchers were able to produce a diverse library of about one million proteins, each 102 amino acids long.
“We had to focus on certain subsets of proteins that we knew would fold and search there first for function,” said Katie Digianantonio, a graduate student in the Hecht lab and first author on the paper. “It’s like instead of searching the whole universe for life, we’re looking in specific solar systems.”
Having found several non-natural proteins that could rescue specific cell lines, this latest work details their investigation specifically into how SynSerB promotes cell growth. The most obvious explanation, that SynSerB simply catalyzed the same reaction performed by the deleted SerB gene, was discounted by an early experiment.
To discern SynSerB’s mechanism among the multitude of complex biochemical pathways in the cell, the researchers turned to a technique called RNA sequencing. This technique allowed them to take a detailed snapshot of the serine-depleted E. Coli cells with and without their synthetic protein and compare the differences.
“Instead of guessing and checking, we wanted to look at the overall environment to see what was happening,” Digianantonio said. The RNA sequencing experiment revealed that SynSerB induced overexpression of a protein called HisB, high levels of which have been shown to promote the key reaction normally performed by the missing gene. By enlisting the help of HisB, the non-natural protein was able to induce the production of serine, which ultimately allowed the cell to survive.
“Life is opportunistic. Some proteins are going to work by acting similarly to what they replaced and some will find another pathway,” Hecht said. “Either way it’s cool.”
Learn more: How an artificial protein rescues dying cells
The Latest on: Synthetic protein
via Google News
The Latest on: Synthetic protein
- Synthetic Antibiotic Neutralizes Drug-Resistant Bacteria in Miceon May 27, 2022 at 2:09 am
A new antibiotic, synthesized at The Rockefeller University and derived from computer models of bacterial gene products, appears to neutralize even drug-resistant bacteria.
- UK biotech Nanosyrinx begins platform play around synthetic biology techon May 26, 2022 at 5:00 pm
A U.K. biotech is aiming to build a new pipeline around a unique drug delivery system employing a naturally occurring protein called a “nanosyringe” to overcome the technical challenges of delivering ...
- A synthetic antibiotic may help turn the tide against drug-resistant pathogenson May 26, 2022 at 11:00 am
A new antibiotic, synthesized at The Rockefeller University and derived from computer models of bacterial gene products appears to neutralize even drug-resistant bacteria. The compound, named ...
- Synthesis raises largest VC fund ever targeting alternative protein sectoron May 26, 2022 at 4:32 am
Alternative protein investor Synthesis has raised more than $300m for its debut fund - the largest VC vehicle ever raised targeting the sector.
- Synthesis Capital closed its first fund with $300M, giving boost to foodtech’s futureon May 25, 2022 at 11:02 am
Synthesis Capital, the one-year-old London-based food technology and alternative protein investor, closed its first fund with over $300 million in capital commitments. The firm is led by former CPT ...
- Synthesis Capital Launches World’s Largest Dedicated Food Technology Venture Capital Fundon May 24, 2022 at 11:00 pm
Over $300m raised to date to support the next wave of disruptive and innovative food tech businesses and alternative protein technology platforms - Synthesis Capital Fund I will ...
- Synthetic Meat Market Report 2022 Growing CAGR, Future Demands, Leading Players, Business Outlook, Competition, Emerging Trends and Forecast to 2028on May 23, 2022 at 11:43 pm
Final Report will add the analysis of the impact of COVID-19 on this industry.” “Synthetic Meat Market” report includes ...
- Peptide Synthesis Market is Projected to Grow at a Rate of 7% CAGR During The Forecast Period 2022-2032on May 23, 2022 at 11:53 am
As per the peptide synthesis market survey by Future Market Insights (FMI), the peptide synthesis market is forecasted to register a CAGR of 7% from 2022 ...
- Superbrewed Food secures self-affirmed GRAS status for 'postbiotic cultured protein, expects first product launches in 2023on May 20, 2022 at 8:54 am
Superbrewed Food has secured self-affirmed GRAS status for a new whole food, non-GMO ingredient - marketed as a ‘postbiotic cultured protein’ – that founder Dr Bryan Tracy is billing as “the most ...
- Peptide Synthesis Market Is Growing Steadily and Is Expected to Ascend USD 546.3 Million by 2027 At Over 6.6% CAGR, says Coherent Market Insightson May 17, 2022 at 5:08 am
Major players operating in the global peptide synthesis market include GenScript Biotech Corporation, Merck KGaA, ThermoFisher Scientific Inc., Syngene, Lonza, Novo Nordisk A/S, Bachem Holding AG, ...
via Bing News